California M-License Operators in a Bifurcated Federal World: A Legal Deep Dive on DOJ’s April 2026 Rescheduling Order

by The Law Office of Shay Aaron Gilmore
On April 22, 2026, Acting Attorney General Todd Blanche signed the most consequential federal cannabis order in more than five decades. The order immediately moves both FDA-approved cannabis products and state-regulated medical cannabis products from Schedule I to Schedule III of the Controlled Substances Act (CSA). At the same time, it launches an expedited administrative hearing — beginning June 29, 2026 — to determine whether broader rescheduling of all marijuana, including adult-use products, should follow.…



A “joint” hearing